Share Twitter LinkedIn Facebook Email Kathleen Mahoney, M.D. Instructor, Medicine, Harvard Medical School Discusses Is The Secreted Variant Of PD-L1 A Systemic Immunosuppressant. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
Immunotherapy Side Effects Under Scrutiny: New Data on Bone Density and T-Cell Insights AACR 3 Mins Read
Immunotherapy Revolution Unveiled: How TLS-Derived Antibodies Are Changing Cancer Treatment AACR Io 2025 AACR 4 Mins Read
AACR IO 2025: Revolutionary Insights into Desmoplastic Melanoma Treatment – Kari L Kendra, MD, PHD AACR 5 Mins Read